查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球动物输液泵市场-2022-2029
市场调查报告书
商品编码
1129271

全球动物输液泵市场-2022-2029

Global Veterinary Infusion Pumps Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

兽医输液泵是用于为重症宠物长时间提供营养液的设备，并且是剂量时尚的。兽医输液泵已成为体液监测和分析各种动物临床问题的一个组成部分。它是一种定期向患者体内输送精确数量的营养、药物和液体的方法。这些泵的推注、预编程和待机模式功能可以完全改变血液製品的给药方式。

市场动态

动物输液泵的技术创新有望推动市场增长。

新的药剂，例如某些生物製剂、基因疗法和其他不能口服、局部或静脉内给药的小分子，需要在植入式给药系统方面取得进步。这种侵入性给药策略直接克服了动物身体构成的生理障碍，将适量的药物释放到治疗部位，并在给药后所需的时间内保持药物的生物活性，以确保药物疗效。保持可用性。微技术的进步使现代 MEMS 植入式药物输液泵具有独特的性能和特点。急性快速放射性标记、用于癌症治疗的纳米药物的短期给药和慢性眼部药物给药是微泵在实验室动物和临床前研究中体内演示的一些例子。此外，微结构研究，如 MEMS 致动器和阀门，可能会导致下一代植入式泵体积小、性能优异，适用于临床应用。因此，从上述陈述来看，预计它将成为预测期内市场的驱动力。

约束

动物输液泵的高成本、对设备批准的严格规定、动物主人缺乏动物健康意识、使用不同给药装置的输液泵错误等将在预测期内阻碍市场。预期因素。

行业分析

动物输液泵市场根据供应链分析、价格分析等各种行业因素对市场进行了深入分析。

COVID-19 影响分析

COVID-19 大流行对医疗保健系统和市场产生了适度影响。出于治疗或诊断目的，输液泵是一种通过静脉 (IV) 或硬膜外方法精确输送液体的机器。与重力计量装置相比，提供更高的压力和更高的精度。输液泵对宠物构成重大风险，因此在管理输液和药物时应格外小心。如果输液速度或容量设置不正确，患者可能会受到伤害。使用任何输液设备时，监控您的宠物非常重要。

另一方面，经济危机将影响农业和兽医服务，更加强调冠状病毒感染对农场和宠物动物的公共卫生影响。此外，大流行将破坏供应炼和流程。许多公司将转移到其他地区以确保产品可用性并保护其供应链。因此，从上面这句话来看，市场受到了影响，预计随着经济活动的恢復，市场将迅速获得牵引力。

全球动物输液泵市场报告将提供对大约 45 多个市场数据表、40 多个数字和 200 页的访问。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 动物输液泵的技术创新有望推动市场增长。
    • 限制因素
      • 动物输液泵的高成本预计将阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 大容量输液泵
  • 注射器式输液泵

第 8 章动人

  • 固定式
  • 便携

第 9 章按渠道类型

  • 单通道
  • 多渠道

第十章註入方式

  • 费率模式
  • 时间模式
  • 剂量模式
  • 其他

第 11 章，最终用户

  • 兽医医院
  • 兽医医院
  • 实验室
  • 家庭护理
  • 其他

第 12 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 13 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准
  • 值得关注的重点公司列表

第 14 章公司简介

  • B.Braun Melsungen AG
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Burtons Medical Equipment Ltd
  • Digicare Biomedical Technology Inc
  • DRE Veterinary
  • Grady Medical System Inc.
  • Heska Corporation
  • Jorgen Kruuse
  • Jorgensen Laboratories
  • Eitan Medical
  • iVet Medical

第15章 全球动物输液泵市场-DataM

简介目录
Product Code: DMVH5839

Market Overview

Veterinary Infusion Pumps Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

The veterinary infusion pump is a device used to deliver nutrient solutions to seriously ill pets over a lengthy period and is dosed fashioned. Veterinarian infusion pumps have been essential in monitoring and analyzing fluids for various clinical problems in animals. It administers a controlled supply of nutrition, drugs, and fluids to the patient's body in precise amounts at regular intervals. These pumps' bolus dosage, preprogramming, and standby mode capabilities can completely change how blood medicines are administered.

Market Dynamics

Innovations in Veterinary Infusion Pumps are expected to drive market growth.

Advancements in implanted drug delivery systems are necessary for novel pharmacological substances, such as particular biologics, gene therapy, and other tiny molecules that cannot be delivered orally, topically, or intravenously. This invasive dosing strategy aims to directly overcome physiological barriers posed by the animal body, release the appropriate medication dosage at the treatment site, and maintain the medication's bioavailability for the necessary period following delivery to ensure medication efficacy. Modern MEMS-enabled implanted medication infusion pumps with distinctive performance and feature sets have been made possible by microtechnological advancements. Acute fast radiolabeling, short-term administration of nanomedicine for cancer treatment, and chronic ocular medication dosage are a few examples of in vivo demonstration of micropumps for laboratory animal research and preclinical studies. Moreover, Next-generation implantable pumps with excellent performance in a small form factor for clinical applications may be made possible through research into MEMS actuators, valves, and other microstructures. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

The high cost of veterinary infusion pumps, stringent regulations for the approvals of the devices, lack of awareness of animal health among the proprietors and errors of fluid infusion pumps using different administration sets are some of the factors the market is expected to get hampered in the forecast period.

Industry Analysis

The veterinary infusion pumps market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. For therapeutic or diagnostic purposes, infusion pumps are machines that accurately provide liquids via intravenous (IV) or epidural methods. Compared to gravity administration sets, they offer higher pressures and greater accuracy. Infusion pumps provide a significant risk to pets, so extra caution should be used while administering IV solutions or medications. The patient may suffer harm if the infusion rate or volume are set incorrectly. Every infusion device should be utilized while the pets are being closely watched.

In contrast, an economic crisis will affect agriculture and veterinary services, and a greater emphasis on the public health effects of coronavirus infections in animals on farms and pets. Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Large-Volume Infusion Pumps segment is expected to hold the largest market share in veterinary infusion pumps market

The large-volume infusion pumps segment is expected to dominate in 2021. The segment benefits as the infusion pumps can be manually or mechanically operated, offering great pain relief, fewer side effects than oral pharmaceutical treatment, and accessibility for daily tasks. Also, various infusion pumps are categorized into several categories based on their size, accuracy, technology, flow rate, battery life, and kind of infusions (continuous, intermittent). Therefore, it has led to the increased usage of large volume infusion pumps for administering parenteral nourishment, delivering fluid for blood transfusions, and in emergencies, with technological advancements in large volume infusion pumps. For instance, the IVVet Veterinary Infusion Pump from Eitan Medical combines the proprietary Flow Control Technology, state-of-the-art hardware design, user-friendly touch-screen, software-controlled pumping mechanism, and low total cost of ownership. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global veterinary infusion pumps market

In 2021, North America accounted for the highest revenue share. The significant growth rate is owing to the increase in animal adaptation rates and healthcare expenditure coupled with rising animal diseases requiring surgeries. The huge number of veterinary practices and product launches by the market players are some factors the market is expected to boost in the forecast period. For instance, according to the American Society for the Prevention of Cruelty to Animals, every year, almost 4.1 million pets are adopted from animal shelters. On average, 2.1 million cats and 2 million dogs are adopted yearly. In contrast to dogs, which are more frequently bought from breeders than adopted, cats are adopted more frequently than they are bought from breeders. Moreover, according to the Veterinary Medical Association 2020, as of December 2020, there were around 75,349 veterinarian private offices in the United States.

Additionally, to establish a national sales presence in the veterinary healthcare equipment industry, DVMPro Inc., a top supplier of veterinary diagnostic equipment for veterinary health professionals, partnered with MTMC Animal Health. The relationship between MTMC and DVMPro will cover the entire product line, which comprises Veterinary Monitoring, Ventilators & Anesthesia, Ultrasound, ECG, Infusion Pumps, Pulse Oximetry, and Blood Analysis. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the veterinary infusion pumps market are B. Braun Melsungen AG, Burtons Medical Equipment Ltd, Digicare Biomedical Technology Inc., DRE Veterinary, Grady Medical System Inc., Heska Corporation, Jorgen Kruuse, Jorgensen Laboratories, Eitan Medical, iVet Medical.

B. Braun Melsungen AG:

Overview:

B. Braun is a German manufacturer of medical and pharmaceutical devices. The B. Braun product line includes 5,000 items, 95 percent of which are manufactured by the company. The company's product portfolio includes infusion, nutrition, pain therapy products, infusion pumps and systems, surgical instruments, suture materials, hip and knee implants, dialysis equipment and accessories, ostomy, disinfection, and wound care products. The company operates its business through five divisions: hospital care, Aesculap, B. Braun Avitum, out-patient market (OPM) and other sales. B. Braun has a presence in 64 countries and develops products in 18 therapy fields of the healthcare industry.

Product Portfolio:

Infusomat Space pump: The Infusomat Space pump is a volumetric infusion pump configured as an individual pump, a small therapy unit, or an advanced infusion system. The pump's compact, lightweight, and user-friendly designs unify all clinical areas into a single system while offering a user-friendly solution to complex therapies.

The global veterinary infusion pumps market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in Veterinary Infusion Pumps are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of veterinary infusion pumps is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Large-Volume Infusion Pumps*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Syringe Infusion Pumps

8. By Mobility

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 8.1.2. Market Attractiveness Index, By Mobility Segment
  • 8.2. Stationary*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Portable

9. By Channel Type

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 9.1.2. Market Attractiveness Index, By Channel Type Segment
  • 9.2. Single Channel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Multi-Channel

10. By Infusion Mode

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 10.1.2. Market Attractiveness Index, By Infusion Mode Segment
  • 10.2. Rate Mode*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Time Mode
  • 10.4. Dose Mode
  • 10.5. Others

11. By End user

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.1.2. Market Attractiveness Index, By End user Segment
  • 11.2. Veterinary Hospitals*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 11.3. Veterinary Clinics
  • 11.4. Laboratories
  • 11.5. Homecare
  • 11.6. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.2.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.3.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Italy
      • 12.3.8.5. Spain
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mobility
    • 12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Channel Type
    • 12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Infusion Mode
    • 12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

13. Competitive Landscape

  • 13.1. Key Developments and Strategies
  • 13.2. Company Share Analysis
  • 13.3. Product Benchmarking
  • 13.4. List of Key Companies to Watch

14. Company Profiles

  • 14.1. B. Braun Melsungen AG*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Key Highlights
    • 14.1.4. Financial Overview
  • 14.2. Burtons Medical Equipment Ltd
  • 14.3. Digicare Biomedical Technology Inc
  • 14.4. DRE Veterinary
  • 14.5. Grady Medical System Inc.
  • 14.6. Heska Corporation
  • 14.7. Jorgen Kruuse
  • 14.8. Jorgensen Laboratories
  • 14.9. Eitan Medical
  • 14.10. iVet Medical

LIST NOT EXHAUSTIVE

15. Global Veterinary Infusion Pumps Market - DataM

  • 15.1. Appendix
  • 15.2. About Us and Applications
  • 15.3. Contact Us